Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes

E-ISSN： 1873-5592|13|4|526-540

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.4, 2012-04, pp. : 526-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibodies to advanced glycation end products in children with diabetes mellitus

By Nicoloff G. Baydanoff S. Petrova C. Christova P.

General Pharmacology, Vol. 39, Iss. 1, 2002-07 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite

Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2096-2102

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced glycation end products and diabetic complications

By Stitt Alan W Jenkins Alicia J Cooper Mark E

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1205-1223

Informa Healthcare

Access to resources Recommend Favorite

The Road to Advanced Glycation End Products: A Mechanistic Perspective

Current Medicinal Chemistry, Vol. 14, Iss. 15, 2007-06 ,pp. : 1653-1671

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Advanced Glycation End Products in Diabetic Neuropathy

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 953-961

Bentham Science Publishers

Access to resources Recommend Favorite